Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial. - Burris, Howard A.; Lebrun, Fabienne; Rugo, Hope S.; Beck, J. Thaddeus; Piccart, Martine; Neven, Patrick; Baselga, Jose; Petrakova, Katarina; Hortobagyi, Gabriel N.; Komorowski, Anna; Chouinard, Edmond; Young, Robyn; et al. (Cancer (0008543X), 2013)